Stacie M. Bratton

1.4k total citations
28 papers, 1.1k citations indexed

About

Stacie M. Bratton is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Stacie M. Bratton has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 16 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Stacie M. Bratton's work include Pharmacogenetics and Drug Metabolism (16 papers), Cannabis and Cannabinoid Research (5 papers) and Cancer therapeutics and mechanisms (5 papers). Stacie M. Bratton is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Cannabis and Cannabinoid Research (5 papers) and Cancer therapeutics and mechanisms (5 papers). Stacie M. Bratton collaborates with scholars based in United States, Finland and Poland. Stacie M. Bratton's co-authors include Anna Radomińska‐Pandya, Moshe Finel, A. Zielińska, Jeffery H. Moran, Michael J. Miley, Matthew R. Redinbo, Paul L. Prather, Jeffrey E. Keenan, Joanna M. Little and Cindy L. Moran and has published in prestigious journals such as Journal of Molecular Biology, Biochemistry and The FASEB Journal.

In The Last Decade

Stacie M. Bratton

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Stacie M. Bratton

Since Specialization

Citations

This map shows the geographic impact of Stacie M. Bratton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacie M. Bratton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacie M. Bratton more than expected).

Fields of papers citing papers by Stacie M. Bratton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacie M. Bratton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacie M. Bratton. The network helps show where Stacie M. Bratton may publish in the future.

Co-authorship network of co-authors of Stacie M. Bratton

This figure shows the co-authorship network connecting the top 25 collaborators of Stacie M. Bratton. A scholar is included among the top collaborators of Stacie M. Bratton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacie M. Bratton. Stacie M. Bratton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines 2015 ·Cancer Biology & Therapy ·(unknown), Tariq Fahmi, (unknown), Aiwei Yao‐Borengasser, (unknown), Stacie M. Bratton, Susan Kadlubar, Peter I. Mackenzie, Randy S. Haun, Anna Radomińska‐Pandya	20
2	A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives 2014 ·Drug Metabolism and Disposition ·(unknown), (unknown), Athena Starlard‐Davenport, Vineetha Koroth Edavana, Stacie M. Bratton, Ishwori Dhakal, Moshe Finel, Susan Kadlubar, Anna Radomińska‐Pandya	11
3	Novel Resveratrol-Based Substrates for Human Hepatic, Renal, and Intestinal UDP-Glucuronosyltransferases 2014 ·Chemical Research in Toxicology ·(unknown), Nikhil Reddy Madadi, Stacie M. Bratton, (unknown), Zofia Mazerska, Howard P. Hendrickson, Peter A. Crooks, Anna Radomińska‐Pandya	8
4	CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen 2013 ·Biochemical and Biophysical Research Communications ·Paul L. Prather, (unknown), (unknown), (unknown), Stacie M. Bratton, Benjamin M. Ford, Lirit N. Franks, Anna Radomińska‐Pandya	23
5	Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands 2012 ·Drug Metabolism and Disposition ·Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton, Lisa K. Brents, Cindy L. Moran, Gregory W. Endres, Laura P. James, Paul F. Hollenberg, Paul L. Prather, Anna Radomińska‐Pandya, Jeffery H. Moran	163
6	Role of Human UDP-Glucuronosyltransferases in the Biotransformation of the Triazoloacridinone and Imidazoacridinone Antitumor Agents C-1305 and C-1311: Highly Selective Substrates for UGT1A10 2012 ·Drug Metabolism and Disposition ·(unknown), Stacie M. Bratton, Moshe Finel, Anna Radomińska‐Pandya, Zofia Mazerska	21
7	Conjugation of Synthetic Cannabinoids JWH-018 and JWH-073, Metabolites by Human UDP-Glucuronosyltransferases 2011 ·Drug Metabolism and Disposition ·Krishna C. Chimalakonda, Stacie M. Bratton, (unknown), (unknown), (unknown), Cindy L. Moran, Laura P. James, Jeffery H. Moran, Anna Radomińska‐Pandya	66
8	Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors 2011 ·Xenobiotica ·Lisa K. Brents, Fabricio Medina-Bolívar, Kathryn A. Seely, Vipin A. Nair, Stacie M. Bratton, (unknown), Ronak Y. Patel, Haining Liu, Robert J. Doerksen, Paul L. Prather, Anna Radomińska‐Pandya	44
9	Human UDP‐glucuronosyltransferases (UGTs) are involved in the metabolism of the natural resveratrol analogues arachidin‐1, arachidin‐3 and piceatannol 2010 ·The FASEB Journal ·Anna Radomińska‐Pandya, Vipin A. Nair, Stacie M. Bratton, (unknown), Paul L. Prather, (unknown)	1
10	The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families 2009 ·Drug Metabolism Reviews ·Anna Radomińska‐Pandya, Stacie M. Bratton, Matthew R. Redinbo, Michael J. Miley	59
11	Identification of Hydroxywarfarin Binding Site in Human UDP Glucuronosyltransferase 1A10: Phenylalanine90 Is Crucial for the Glucuronidation of 6- and 7-Hydroxywarfarin but Not 8-Hydroxywarfarin 2008 ·Drug Metabolism and Disposition ·Grover P. Miller, Cheryl F. Lichti, A. Zielińska, Anna Mazur, Stacie M. Bratton, (unknown), Moshe Finel, Jeffery H. Moran, Anna Radomińska‐Pandya	12
12	Effect of Retinoids on UDP-Glucuronosyltransferase 2B7 mRNA Expression in Caco-2 Cells 2008 ·Drug Metabolism and Pharmacokinetics ·Yuan Lu, Stacie M. Bratton, Jean‐Marie Heydel, (unknown)	15
13	Human UGT1A8 and UGT1A10 mRNA Are Expressed In Primary Human Hepatocytes 2007 ·Drug Metabolism and Pharmacokinetics ·Xin Li, Stacie M. Bratton, Anna Radomińska‐Pandya	11
14	Crystal Structure of the Cofactor-Binding Domain of the Human Phase II Drug-Metabolism Enzyme UDP-Glucuronosyltransferase 2B7 2007 ·Journal of Molecular Biology ·Michael J. Miley, A. Zielińska, Jeffrey E. Keenan, Stacie M. Bratton, Anna Radomińska‐Pandya, Matthew R. Redinbo	153
15	Glucuronidation of Monohydroxylated Warfarin Metabolites by Human Liver Microsomes and Human Recombinant UDP-Glucuronosyltransferases 2007 ·Journal of Pharmacology and Experimental Therapeutics ·A. Zielińska, Cheryl F. Lichti, Stacie M. Bratton, (unknown), (unknown), (unknown), Moshe Finel, Grover P. Miller, Anna Radomińska‐Pandya, Jeffery H. Moran	34
16	The First Aspartic Acid of the DQxD Motif for Human UDP-Glucuronosyltransferase 1A10 Interacts with UDP-Glucuronic Acid during Catalysis 2007 ·Drug Metabolism and Disposition ·(unknown), (unknown), Michael J. Miley, A. Zielińska, Stacie M. Bratton, Grover P. Miller, Adrian Goldman, Moshe Finel, (unknown), Anna Radomińska‐Pandya	14
17	Phenylalanine90 and phenylalanine93 are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10 2006 ·Steroids ·Athena Starlard‐Davenport, (unknown), Stacie M. Bratton, (unknown), Moshe Finel, Anna Radomińska‐Pandya	33
18	LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT 2005 ·Drug Metabolism and Disposition ·Yuan Lü, Jean‐Marie Heydel, Xin Li, Stacie M. Bratton, Tim H. Lindblom, Anna Radomińska‐Pandya	45
19	A Historical Overview of the Heterologous Expression of Mammalian UDP-Glucuronosyltransferase Isoforms Over the Past Twenty Years 2005 ·Current Drug Metabolism ·Anna Radomińska‐Pandya, Stacie M. Bratton, Joanna M. Little	50
20	Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases 2004 ·Journal of Lipid Research ·Joanna M. Little, Mika Kurkela, (unknown), Sirkku Jäntti, Raimo A. Ketola, Stacie M. Bratton, Moshe Finel, Anna Radomińska‐Pandya	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact